Frontiers in Pharmacology | Respiratory Pharmacology

Case Report

Published on 22 Nov 2024

Rare cancer with primary pleural epithelioid hemangioendothelioma diagnosed by thoracoscopic biopsy achieving disease control after 16 months: case report and literature review

in Respiratory Pharmacology

Ioannis S. Pateras
Konstantinos Kostopanagiotou
Menelaos G. Samaras
Anna Koumarianou
Mina Koutrouli
Nikolaos Korodimos
Katerina Kampoli
Vasiliki Apollonatou
Effrosyni Manali
Stylianos Loukides

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1482154

1,358 views

Review

Published on 13 Nov 2024

Pyroptosis in asthma: inflammatory phenotypes, immune and non-immune cells, and novel treatment approaches

in Respiratory Pharmacology

Yuqiu Hao
Wenrui Wang
Lin Zhang
Wei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1452845

1,906 views
1 citation

Review

Published on 08 Nov 2024

Bacteria and fungi of the lung: allies or enemies?

in Respiratory Pharmacology

Enrico Garaci
Marilena Pariano
Emilia Nunzi
Claudio Costantini
Marina Maria Bellet
Cinzia Antognelli
Matteo Antonio Russo
Luigina Romani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497173

2,136 views
1 citation

Case Report

Published on 07 Nov 2024

Characteristics of voriconazole-induced visual disturbances and hallucinations: case reports and literature review

in Respiratory Pharmacology

Ya Liu
Ying Huang
Xiang Liu
Danxia Wang
Yixiang Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420046

1,937 views
2 citations

Original Research

Published on 28 Oct 2024

Therapeutic targets for lung cancer: genome-wide Mendelian randomization and colocalization analyses

in Respiratory Pharmacology

Yi Luan
Desheng Xian
Changwen Zhao
Xin Qing
Hanlin He
Kaixuan Zheng
Wenjun Song
Taijiao Jiang
Wenjian Wang
Chaohui Duan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1441233

3,190 views

Correction

Published on 25 Oct 2024

Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder

in Respiratory Pharmacology

Cataldo Martucci
Andrew Dennis Allen
Nadia Moretto
Valentina Bagnacani
Alessandro Fioni
Riccardo Patacchini
Maurizio Civelli
Gino Villetti
Fabrizio Facchinetti

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497520

598 views
1 citation

Review

Published on 09 Oct 2024

Emerging small-molecule antiviral agents in long COVID prevention

in Respiratory Pharmacology

Xiaomeng He
Xiang Zhang
Wu Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1457672

3,132 views

Review

Published on 08 Oct 2024

Current landscape of cystic fibrosis gene therapy

in Respiratory Pharmacology

Lindsey W. Plasschaert
Kelvin D. MacDonald
Jeffrey S. Moffit

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476331

9,856 views
8 citations

Original Research

Published on 25 Sep 2024

Airspaces-derived exosomes contain disease-relevant protein signatures in a mouse model of cystic fibrosis (CF)-like mucoinflammatory lung disease

in Respiratory Pharmacology

Yun Mao
Amol Suryawanshi
Sonika Patial
Yogesh Saini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1460692

2,369 views
1 citation

Review

Published on 24 Sep 2024

The critical roles of caveolin-1 in lung diseases

in Respiratory Pharmacology

Jiarun Fan
Siping Zheng
Maoping Wang
Xiaoliang Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1417834

3,634 views
5 citations

Review

Published on 23 Sep 2024

3D cell culture models in research: applications to lung cancer pharmacology

in Respiratory Pharmacology

Nathan Vella
Anthony G. Fenech
Vanessa Petroni Magri

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438067

5,809 views
4 citations

Original Research

Published on 19 Sep 2024

The glucocorticoid dose-mortality nexus in pneumonia patients: unveiling the threshold effect

in Respiratory Pharmacology

Saibin Wang
Qian Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1445979

1,018 views

Original Research

Published on 13 Sep 2024

Aspirin reduces the mortality risk of patients with community-acquired pneumonia: a retrospective propensity-matched analysis of the MIMIC-IV database

in Respiratory Pharmacology

Guangdong Wang
Jiaolin Sun
Yaxin Zhang
Na Wang
Tingting Liu
Wenwen Ji
Lin Lv
Xiaohui Yu
Xue Cheng
Mengchong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1402386

5,006 views
1 citation

Original Research

Published on 11 Sep 2024

Triiodothyronine acts on DAO to regulate pulmonary fibrosis progression by facilitating cell senescence through the p53/p21 signaling pathway

in Respiratory Pharmacology

Xiaoshu Guo
Kai Xu
Lan Wang
Linke Ding
Wenwen Li
Xinsheng Zhang
Weiming Zhao
Ningdan Wang
Gaiping Wang
Wenyu Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1433186

1,961 views
1 citation

Original Research

Published on 06 Sep 2024

Dopamine, norepinephrine, and vasopressin accelerate particle transport velocity in murine tracheal epithelium via substance-specific receptor pathways: dependency on intra- and extracellular Ca2+ sources

in Respiratory Pharmacology

Götz Schmidt
Isabelle Greif
Sabrina Müller
Melanie Markmann
Fabian Edinger
Michael Sander
Christian Koch
Michael Henrich

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401983

1,410 views
1 citation

Review

Published on 30 Aug 2024

Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?

in Respiratory Pharmacology

Karol Bączek
Wojciech Jerzy Piotrowski

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1445923

4,925 views
3 citations